<div>Developmental disorders with structural birth defects account for the majority of morbidity and mortality in children's hospitals, and the genetic bases of many clinical phenotypes remain unknown. Genetic testing for individuals with structural malformations has uncovered the basis of many such birth defects; however, many more cases remain unsolved, posing challenges for diagnosis, treatment, and prevention. Multiple anomaly conditions are particularly challenging to diagnose, since they often present with unique combinations of clinical features that vary widely between affected individuals, even in the same family. CHARGE Syndrome (Coloboma of the eye, Heart Defects, Atresia of the choanae, Retardation of growth and development, Genital abnormalities including pubertal delay and infertility, Ear abnormalities with deafness and vestibular disorders) is a multiple anomaly condition that affects a wide variety of organ systems. CHARGE Syndrome is caused in most cases by monoallelic pathogenic variants in <a href="https://www.ncbi.nlm.nih.gov/gene/55636">CHD7</a>, the gene encoding ATP-dependent helicase chromodomain DNA binding protein 7. Both <i>de novo</i> and inherited variants in <a href="https://www.ncbi.nlm.nih.gov/gene/55636">CHD7</a> have been reported in CHARGE, and a growing number of families present with individuals who test positive for a pathogenic <a href="https://www.ncbi.nlm.nih.gov/gene/55636">CHD7</a> variant yet exhibit only mild features. Similarly, individuals with CHARGE Syndrome often exhibit broad variability and reduced penetrance of clinical features, consistent with pleiotropic roles for <a href="https://www.ncbi.nlm.nih.gov/gene/55636">CHD7</a> during development and/or additional genetic contributors or modifying alleles. Recent work has also implicated <a href="https://www.ncbi.nlm.nih.gov/gene/473">RERE</a>, <a href="https://www.ncbi.nlm.nih.gov/gene/8085">KMT2D</a>, <a href="https://www.ncbi.nlm.nih.gov/gene/2033">EP300</a>, and <a href="https://www.ncbi.nlm.nih.gov/gene/22827">PUF60</a> in having a role in CHARGE Syndrome.</div><br><div>We hypothesize that (1) some cases of CHARGE are due to other genetic etiologies including oligogenicity, and (2) genetic modifiers contribute to the broad clinical variability and reduced penetrance of CHARGE features. To address these hypotheses, we have generated a cohort of 223 deeply clinically phenotyped individuals with CHARGE Syndrome and related disorders and structural anomalies who tested negative by chromosomal microarray, single gene sequencing, next generation panel sequencing, or exome sequencing. These individuals exhibit clinical CHARGE-like features including structural birth defects affecting craniofacial, ocular, neurosensory, brain, heart, mediastinal, renal, genitourinary, and skeletal organs. Our cohort includes these 223 individuals as well as affected and unaffected family members who consented to clinical and research genetic testing and donated blood samples for DNA and RNA isolation and sequencing. Building on this valuable cohort, we propose to use exome and genome sequencing to identify novel genetic etiologies of CHARGE and related developmental disorders for which alternative genetic tests have been inconclusive. Identification of novel pathogenic genetic variants and contributing modifier alleles within the coding and non-coding portion of the genome of these individuals will improve genetic diagnosis and provide important insights toward understanding the developmental mechanisms of structural birth defects.<br></div><br><div> </div>

Kids First: Genomic Etiologies of CHARGE Syndrome, Related Conditions and Structural Anomalies

Genetic analysis of CHARGE syndrome identifies overlapping molecular biology